Roche says did not collude with Novartis to restrict competition
ZURICH, April 10
ZURICH, April 10 (Reuters) - Swiss drugmaker Roche said on Thursday that it had not colluded with Novartis to restrict competition for eye disease treatments.
"Roche confirms there is no agreement between Roche and Novartis that restricts competition," the drugmaker said in a statement.
Earlier on Thursday, the companies said France's competition authority was investigating them on suspicion they were involved in anti-competitive practices in relation to treatment for wet age-related macular degeneration (AMD). (Reporting by Caroline Copley; Editing by Pravin Char)
- Nurse defies Ebola quarantine with bike ride; negotiations fail |
- Japan shares soar, yen skids after BOJ stuns with new easing steps
- Suspect in Pennsylvania police ambush captured after seven-week manhunt
- Oil price declines have small-cap shale investors scrambling
- China says nets 180 graft suspects in overseas manhunt